MA (EU) Number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/22/1671/001 
EU/1/22/1671/002 
Sunlenca 
Sunlenca   
300 mg 
464 mg 
Film-coated tablet  Oral use 
Solution for 
injection 
Subcutaneous 
use 
blister (PVC/alu) 
vial (glass) 
1.5 ml 
(309 mg/ml) 
5 tablets  
2 vials+ 2 vial 
access devices + 
2 syringes + 2 
needles  
1/1 
 
 
 
